Blood Glucose Control Strategy for Type 2 Diabetes Patients With COVID-19.
Front Cardiovasc Med
; 7: 593061, 2020.
Artículo
en Inglés
| MEDLINE | ID: covidwho-1485041
ABSTRACT
Since December 2019, coronavirus disease 2019 (COVID-19) caused by a novel coronavirus has spread all over the world affecting tens of millions of people. Another pandemic affecting the modern world, type 2 diabetes mellitus is among the major risk factors for mortality from COVID-19. Current evidence, while limited, suggests that proper blood glucose control may help prevent exacerbation of COVID-19 even in patients with type 2 diabetes mellitus. Under current circumstances where the magic bullet for the disease remains unavailable, it appears that the role of blood glucose control cannot be stressed too much. In this review the profile of each anti-diabetic agent is discussed in relation to COVID-19.
Texto completo:
Disponible
Colección:
Bases de datos internacionales
Base de datos:
MEDLINE
Tipo de estudio:
Estudio pronóstico
Idioma:
Inglés
Revista:
Front Cardiovasc Med
Año:
2020
Tipo del documento:
Artículo
País de afiliación:
Fcvm.2020.593061
Similares
MEDLINE
...
LILACS
LIS